CH
抗体药类似物
Research Grade Afasevikumab
All
  • CatalogTD-HS856076
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsMCAF-5352A, MCAF5352A, NI-1401, RG-7624, RG7624, RO5553110, CAS: 1589503-30-9
  • Specification
    1mg
  • Prices
    ¥询价
Customized service consulting

Research Grade Afasevikumab


Catalog No. TD-HS856076
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1-kappa
Expression system Mammalian Cells
Species Human
Clonality Monoclonal
Target CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, IL17F, Interleukin-17F, IL-17F, Cytokine ML-1
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession Q16552 & Q96PD4
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names MCAF-5352A, MCAF5352A, NI-1401, RG-7624, RG7624, RO5553110, CAS: 1589503-30-9
Background Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities.
Note For research use only. Not suitable for clinical or therapeutic use.